Description
An allosteric Hb modifier that reduces the affinity of Hb for oxygen, increasing the diffusion of oxygen from blood to tissue; increases p50 from 26.75 to 38.63 mm Hg and decreases the percent Hb-O2 saturation from 48 to 33.8% at a pO2 of 26 mm Hg in isolated human whole blood at 1.75 mM; increases tumor pO2 from 5.2 to 13.1 mm Hg 30 minutes after administration in a RIF-1 mouse fibrosarcoma flank tumor model at 150 mg/kg; enhances radiation-induced cytotoxicity in EMT6 mouse breast cancer cells grown under hypoxic conditions at 100 μM; increases radiosensitization and inhibits tumor growth in a hypoxic Lewis lung tumor mouse model at 100 mg/kg; increases the running capacity of normal mice and mice with LCA ligation-induced MI at 150 mg/kg
Formal name: 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methyl-propanoic acid
Synonyms: RSR 13
Molecular weight: 341.4
CAS: 131179-95-8
Purity: ≥98%
Formulation: A crystalline solid